Find Paper, Faster
Example:10.1021/acsami.1c06204 or Chem. Rev., 2007, 107, 2411-2502
BRD4 inhibition protects against myocardial ischemia/reperfusion injury by suppressing inflammation and oxidative stress through PI3K/AKT signaling pathway.
Journal of Cardiovascular Pharmacology  (IF3.105),  Pub Date : 2021-09-08, DOI: 10.1097/fjc.0000000000001138
Hongwei Wei, Qingjian Xue, Lei Sun, Jie Lv

This study aims to investigate the effect and the related mechanisms of bromodomain containing protein 4 (BRD4) inhibition on myocardial ischemia/ reperfusion (I/R) injury. In vivo and in vitro myocardial I/R models were constructed. Expression of BRD4 was examined by RT-qPCR and Western blot. I/R injury was evaluated by analyzing cardiac function and the activity of biochemical markers of myocardial injury. Inflammation and oxidative stress were determined by measuring the levels of myeloperoxidase (MPO), TNF-α, IL-6, malondialdehyde (MDA) and superoxide dismutase (SOD). The activation of PI3K/AKT signaling pathway was tested by the phosphorylation of p85 and AKT. We found BRD4 was significantly increased in the myocardial tissues following myocardial I/R injury. BRD4 inhibition suppressed the indices of cardiac function and the biochemical markers of myocardial injury. I/R-induced inflammation and oxidative stress were suppressed by shBRD4 in vivo and in vitro. In addition, BRD4 inhibition significantly increased the relative protein expression levels of p-p85, p-AKT T308 and p-AKT S473. In conclusion, this study for the first time demonstrated the protective effect of BRD4 inhibition on myocardial I/R injury in vivo and in vitro, and this effect was related to the suppression of inflammation and oxidative stress through the activation of PI3K/AKT signaling pathway.